Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oxygen saturation, SARS-CoV-2 test, Vaccination failure, Vital signs measurement
Clinical narrative: did get a positive COVID case after receiving the Pfizer, both of them, a month later; did get a positive COVID case after receiving the Pfizer, both of them, a month later; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 24Feb2021 15:00 (Lot: EM9810) as 1 st dose, single then on 22Mar2021 10:00 (Lot: ER2613) as 2 nd dose, single; both via an unspecified route of administration in right deltoid (at the age of 64-years-old) for covid-19 immunisation. The vaccination facility type was a clinic and was not administered at a military facility. No additional vaccines administered on same date of bnt162b2 and no prior vaccinations (within 4 weeks). No events following prior vaccination. Medical history included ongoing hypertension (diagnosed more than 15 years ago), ongoing arthritis reactive (diagnosed probably 10 years ago, maybe 15 years ago), obesity (thinks too heavy for her height, not severely obese) and non-smoker (not former smoker). No family medical history. Concomitant medication included methotrexate for arthritis. On 24Apr2021, the patient experienced sore throat, severe cough, headache, body aches and fatigue which were considered non-serious. The cough lingered and she was a little bit more tired than normal, but she has some of that anyway. The patient recovered completely from everything except the fatigue, still having a little bit of fatigue, it was ongoing, not bad, improved. On 26Apr2021, the patient did get a positive COVID (Covid 19 PCR) case after receiving the Pfizer, both of them, a month later which was considered non-serious. No antibody testing and antigen test done. The patient stated that when she called her doctor, they did advise that she get the Monoclonal antibody infusion. Therapies for COVID-19 included monoclonal antibody infusion, it was a 2 to 3 hour procedure at the hospital. It was an experimental thing, she signed all the forms, it was supposed to boost all her antibodies, hopefully it boosted hers between Covid and that she should be good she was hoping. The patient went to her physician's office for a COVID test. The patient got her first symptom on 24Apr2021. The patient had been contacted that she had been exposed to somebody else who also had been immunized. The patient was with her, she contacted her and then developed symptoms on 24Apr2021 and she didn't go in to get tested until Monday, 26Apr2021. The patient considered it very mild, but she did get the antibody infusion also when she got it. All of the events required a visit to the physician's office but not on emergency room. The patient was not hospitalized, not admitted to an intensive care unit. The patient did not display clinical signs at rest indicative of severe systemic illness. The patient monitored her oxygen levels twice a day and they were fine. They sent her a home monitoring set up, she took her vital signs twice a day for two weeks and everything was fine. The patient did not require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The new or worsened symptoms/signs during the COVID-19 illness experienced was cough but no on the following: multiorgan failure, respiratory, dyspnea, tachypnea, hypoxemia, COVID pneumonia, respiratory failure, acute respiratory distress syndrome. On cardiovascular, no heart failure, cardiogenic shock, acute myocardial infarction, arrhythmia, myocarditis and other. On Gastrointestinal/Hepatic, no vomiting, diarrhea, abdominal pain, jaundice, acute liver failure and other. On vascular, no deep vein thrombosis, pulmonary embolism, limb ischemia, vasculitis and other. On renal, no acute kidney injury, renal failure and other. On neurological, no altered consciousness, convulsions/seizures, encephalopathy, meningitis, cerebrovascular accident and other. On hematological, no thrombocytopenia, disseminated intravascular coagulation and other. On dermatological, no chilblains, erythema multiforme and other. The events did not require initiation of new medication or other treatment or procedure. No pre-existing diseases worsened during the SARS-COV2 infection. The patient was retired now, but she worked as an RN. The outcome of the events was recovered in 2021. The patient considered the events "did get a positive COVID case after receiving the Pfizer, both of them, a month later" were unrelated to bnt162b2.  Follow-up attempts are needed. Further information is expected.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation.